We have detected that you are using an Ad Blocker. PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
No comments yet, be the first to start the discussion!
Bogdan Cristian Dinu
curative intent. seem to be more accurate.
Comment deleted by Moderator.
Endocrine therapy with ovarian suppression/AI/CDK4/6 inhibitor
endocrine therapy with ovarian suppression / AI/ CDK4/6 inhibitor
Endocrine therapy with Ovarian suppression/AI treatment Metastatic disease is generally not curable
Treat with curative intent as described with SBRT in metastatic areas and long term ádjuvant"endocrine therapy with AI/CDK4/6 inhibitor. Despite incurable disease this approach will probably bring the best long term survival...
Curative intent with SBRT
Would treat the oligometastatic disease with SBRT and then begin AI/CDK 4/6 inhibitor. If still in remission at 2 years, stop the CDK and continue AI with close followup.
Pending Moderator approval.
Are you sure you want to delete this comment? This can't be undone.